The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years ...

Most Americans in a new poll said they probably won’t get an updated COVID-19 vaccine. The Pew Research Center survey found ...

Chris Boshoff will be tasked with choosing and developing Pfizer's next major sources of revenue — an increasingly crucial ...

Chris Boshoff will take over as Pfizer’s next chief scientific officer as of January 1, replacing Mikael Dolsten who led the ...

Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.

Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...